Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented, it ...
SCIENTISTS have said that human-induced climate change increased the severity of the 2021-2022 drought in the Horn of Africa.
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results